MedPath

AMVASC BE

Brand Name: AMVASC BE

Generic Name: Amlodipine Besilate

Active
Registration Number

DRP-1195

Dosage Form

Tablet

Issuance Date

July 1, 2022

Expiry Date

October 9, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 mg
PackagingFlex Foil x 10s

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Calcium Channel Blockers (Dihydropyridine derivatives)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Amlodipine BesilateActive
Monograph: Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform